We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Ethnic, Racial, and Sex-Specific Factors Are Important in Cardiovascular Pharmacotherapeutics

Vincent J. Caracciolo, MD; Benjamin M. Shaefer, MD; Pamela Charney, MD
Arch Intern Med. 2002;162(21):2494. doi:.
Text Size: A A A
Published online


In recent years, attention has been focused on genetic polymorphisms as reported recently by Flockhart and Tanus-Santos.1 However, ethnic, racial, and sex-specific genetic factors may also lead to differences in cardiovascular pharmacotherapeutics and are not acknowledged in their current review.

Racial differences in CYP2D6 have been documented, which are also not included in the review by Flockhart and Tanus-Santos. CYP2D6 oxidizes several β-receptor antagonists, most notably metoprolol.2 Many CYP2D6 polymorphisms, conferring phenotypic differences in enzyme function, have been reported. Patients are described as extensive or poor metabolizers. Most alleles identified cause a loss of function or decreased function. Poor metabolizer phenotypes have been estimated at 1% in Chinese subjects compared with 7% in white subjects.3 During long-term oral administration of metoprolol to Chinese patients with poor metabolizer genotype CYP2D6 *10A, subjects demonstrated higher steady state level of metoprolol racemates.3 Some authors suggest that the poor metabolizer prevalence is why Asians and possibly whites may require lower doses of metoprolol for a significant clinical response. Other alleles lead to an increased metabolic activity by gene duplication described as an ultrarapid metabolizer phenotype. Gene duplication has been observed in Saudi Arabians and Ethiopians.4

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed